Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - general hospital - the administration set is to be used for injection (administration) of novo nordisk factor products and contains: 1 sterile infusion set (tubing and butterfly with needle protection), 2 sterile alcohol swabs, 2 sterile gauze pads and 2 sterile plasters

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - general hospital - intended to deliver novo nordisk insulin products packaged in a 3 ml penfill® cartridge and used together with novofine® needles.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novo nordisk pharma (malaysia) sdn. bhd. - insulin aspart -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novo nordisk pharma (malaysia) sdn. bhd. - insulin aspart -

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - insulin aspart - injection - 100 u/ml - insulin aspart 100 u/ml

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - general hospital - novo pen echo® is a re-usable mechanically driven pen injector designed for single-patient use by diabetics for the self-injection of a desired dose of insulin a dose setting range of 0.5 to 30 units in one half (1/2) unit increments.

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - protamine-crystallised insulin aspart; soluble insulin aspart - injection - 70.00% - protamine-crystallised insulin aspart 70%; soluble insulin aspart 30%

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - eptacog alfa (activated)/rfviia - injection, powder, for solution - 1mg - eptacog alfa (activated)/rfviia 1mg

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - eptacog alfa (activated)/rfviia - injection, powder, for solution - 2mg - eptacog alfa (activated)/rfviia 2mg

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - histidine, quantity: 12.57 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - novoseven rt is indicated for the control of bleeding and surgical prophylaxis in patients: with inhibitors to coagulation factors viii or ix; with congenital fvii deficiency; with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.